169 related articles for article (PubMed ID: 32418172)
1. Metabolic syndrome and its components in adult hypopituitary patients.
Abe SY; Dos Santos KS; Barbosa BFB; Biondo CMP; Takito D; Hayashi SK; Amarilla VGV; Ulbrich AZ; Boguszewski CL
Pituitary; 2020 Aug; 23(4):409-416. PubMed ID: 32418172
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and characteristics of the metabolic syndrome in 2479 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.
Verhelst J; Mattsson AF; Luger A; Thunander M; Góth MI; Koltowska-Häggström M; Abs R
Eur J Endocrinol; 2011 Dec; 165(6):881-9. PubMed ID: 21969523
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of metabolic syndrome in adult hypopituitary growth hormone (GH)-deficient patients before and after GH replacement.
Attanasio AF; Mo D; Erfurth EM; Tan M; Ho KY; Kleinberg D; Zimmermann AG; Chanson P;
J Clin Endocrinol Metab; 2010 Jan; 95(1):74-81. PubMed ID: 19897679
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid replacement is associated with hypertriglyceridaemia, elevated glucose and higher non-HDL cholesterol and may diminish the association of HDL cholesterol with the -629C>A CETP promoter polymorphism in GH-receiving hypopituitary patients.
Dullaart RP; Schols JL; van der Steege G; Zelissen PM; Sluiter WJ; van Beek AP
Clin Endocrinol (Oxf); 2008 Sep; 69(3):359-66. PubMed ID: 18221399
[TBL] [Abstract][Full Text] [Related]
5. Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients.
Yuan XX; Zhu HJ; Pan H; Chen S; Liu ZY; Li Y; Wang LJ; Lu L; Yang HB; Gong FY
World J Gastroenterol; 2019 Apr; 25(14):1741-1752. PubMed ID: 31011258
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the metabolic syndrome in moderately-severely obese subjects with and without growth hormone deficiency.
Di Somma C; Pivonello R; Pizza G; De Rosa A; Lombardi G; Colao A; Savastano S
J Endocrinol Invest; 2010 Mar; 33(3):171-7. PubMed ID: 19794297
[TBL] [Abstract][Full Text] [Related]
7. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese and hypopituitary patients.
Cordido F; Alvarez-Castro P; Isidro ML; Casanueva FF; Dieguez C
Eur J Endocrinol; 2003 Aug; 149(2):117-22. PubMed ID: 12887288
[TBL] [Abstract][Full Text] [Related]
8. Aspects of growth hormone deficiency and replacement in elderly hypopituitary adults.
Feldt-Rasmussen U; Wilton P; Jonsson P; ;
Growth Horm IGF Res; 2004 Jun; 14 Suppl A():S51-8. PubMed ID: 15135778
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of pituitary hormone dysfunction, metabolic syndrome, and impaired quality of life in retired professional football players: a prospective study.
Kelly DF; Chaloner C; Evans D; Mathews A; Cohan P; Wang C; Swerdloff R; Sim MS; Lee J; Wright MJ; Kernan C; Barkhoudarian G; Yuen KC; Guskiewicz K
J Neurotrauma; 2014 Jul; 31(13):1161-71. PubMed ID: 24552537
[TBL] [Abstract][Full Text] [Related]
10. Preoperative growth hormone (GH) peak values during a GH releasing peptide-2 test reflect the severity of hypopituitarism and the postoperative recovery of GH secretion in patients with non-functioning pituitary adenomas.
Soga A; Fukuda I; Kobayashi S; Tahara S; Morita A; Sugihara H
Endocr J; 2020 Feb; 67(2):167-175. PubMed ID: 31776295
[TBL] [Abstract][Full Text] [Related]
11. Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease.
Feldt-Rasmussen U; Abs R; Bengtsson BA; Bennmarker H; Bramnert M; Hernberg-Ståhl E; Monson JP; Westberg B; Wilton P; Wüster C;
Eur J Endocrinol; 2002 Jan; 146(1):67-74. PubMed ID: 11751070
[TBL] [Abstract][Full Text] [Related]
12. Frequent development of combined pituitary hormone deficiency in patients initially diagnosed as isolated growth hormone deficiency: a long term follow-up of patients from a single center.
Otto AP; França MM; Correa FA; Costalonga EF; Leite CC; Mendonca BB; Arnhold IJ; Carvalho LR; Jorge AA
Pituitary; 2015 Aug; 18(4):561-7. PubMed ID: 25315032
[TBL] [Abstract][Full Text] [Related]
13. The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma.
Kendall-Taylor P; Jönsson PJ; Abs R; Erfurth EM; Koltowska-Häggström M; Price DA; Verhelst J
Eur J Endocrinol; 2005 Apr; 152(4):557-67. PubMed ID: 15817911
[TBL] [Abstract][Full Text] [Related]
14. Hypopituitarism.
Ascoli P; Cavagnini F
Pituitary; 2006; 9(4):335-42. PubMed ID: 17077946
[TBL] [Abstract][Full Text] [Related]
15. Disease burden and associated risk factors for metabolic syndrome among adults in Ethiopia.
Solomon S; Mulugeta W
BMC Cardiovasc Disord; 2019 Oct; 19(1):236. PubMed ID: 31655560
[TBL] [Abstract][Full Text] [Related]
16. Development of growth hormone and adrenocorticotropic hormone deficiencies in patients with prenatal or perinatal-onset hypothalamic hypopituitarism having invisible or thin pituitary stalk on magnetic resonance imaging.
Miyamoto J; Hasegawa Y; Ohnami N; Onigata K; Kinoshita E; Nishi Y; Tachibana K; Hasegawa T
Endocr J; 2001 Jun; 48(3):355-62. PubMed ID: 11523907
[TBL] [Abstract][Full Text] [Related]
17. Reproducibility of the insulin tolerance test (ITT) for assessment of growth hormone and cortisol secretion in normal and hypopituitary adult men.
Pfeifer M; Kanc K; Verhovec R; Kocijancic A
Clin Endocrinol (Oxf); 2001 Jan; 54(1):17-22. PubMed ID: 11167921
[TBL] [Abstract][Full Text] [Related]
18. Acquired prolactin deficiency (APD) after treatment for Cushing's disease is a reliable marker of irreversible severe GHD but does not reflect disease status.
Mukherjee A; Murray RD; Teasdale GM; Shalet SM
Clin Endocrinol (Oxf); 2004 Apr; 60(4):476-83. PubMed ID: 15049963
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of diabetes mellitus in 6050 hypopituitary patients with adult-onset GH deficiency before GH replacement: a KIMS analysis.
Abs R; Mattsson AF; Thunander M; Verhelst J; Góth MI; Wilton P; Kołtowska-Häggström M; Luger A
Eur J Endocrinol; 2013 Mar; 168(3):297-305. PubMed ID: 23211573
[TBL] [Abstract][Full Text] [Related]
20. Coronary risk in growth hormone deficient hypopituitary adults: increased predicted risk is due largely to lipid profile abnormalities.
Abdu TA; Neary R; Elhadd TA; Akber M; Clayton RN
Clin Endocrinol (Oxf); 2001 Aug; 55(2):209-16. PubMed ID: 11531927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
